These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 17705053)

  • 41. Increased mean platelet volume in patients with acute coronary syndromes.
    Lippi G; Filippozzi L; Salvagno GL; Montagnana M; Franchini M; Guidi GC; Targher G
    Arch Pathol Lab Med; 2009 Sep; 133(9):1441-3. PubMed ID: 19722752
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Polish Registry of Acute Coronary Syndromes (PL-ACS). Characteristics, treatments and outcomes of patients with acute coronary syndromes in Poland.
    Poloński L; Gasior M; Gierlotka M; Kalarus Z; Cieśliński A; Dubiel JS; Gil RJ; Ruzyłło W; Trusz-Gluza M; Zembala M; Opolski G
    Kardiol Pol; 2007 Aug; 65(8):861-72; discussion 873-4. PubMed ID: 17853315
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A correlation study between mean platelet volume and platelet aggregation study in acute coronary syndrome patients.
    Navya PT; Natarajan M
    Indian J Pathol Microbiol; 2024 Jul; 67(3):592-595. PubMed ID: 38391383
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Patients with non-ST-elevation myocardial infarction and without chest pain are treated less aggressively and experience higher in-hospital mortality.
    Zdzienicka J; Siudak Z; Zawiślak B; Dziewierz A; Rakowski T; Dubiel J; Dudek D
    Kardiol Pol; 2007 Jul; 65(7):769-75; discussion 776-7. PubMed ID: 17694458
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The prognostic value of admission mean platelet volume to platelet count ratio in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Bolat I; Akgul O; Cakmak HA; Pusuroglu H; Somuncu U; Ozbey S; Ornek V; Erturk M; Gul M
    Kardiol Pol; 2016; 74(4):346-55. PubMed ID: 26365942
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gamma-glutamyltransferase in acute coronary syndrome patients without ST elevation and its association with stenotic lesion and cardiac events.
    Dogan A; Icli A; Aksoy F; Varol E; Erdogan D; Ozaydin M; Kocyigit S
    Coron Artery Dis; 2012 Jan; 23(1):39-44. PubMed ID: 22107801
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gene expression profiling reveals multiple differences in platelets from patients with stable angina or non-ST elevation acute coronary syndrome.
    Colombo G; Gertow K; Marenzi G; Brambilla M; De Metrio M; Tremoli E; Camera M
    Thromb Res; 2011 Aug; 128(2):161-8. PubMed ID: 21420725
    [TBL] [Abstract][Full Text] [Related]  

  • 48. ADAMTS4 level in patients with stable coronary artery disease and acute coronary syndromes.
    Zha Y; Chen Y; Xu F; Li T; Zhao C; Cui L
    Biomed Pharmacother; 2010 Mar; 64(3):160-4. PubMed ID: 19944557
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Characterization and outcomes of women and men with non-ST-segment elevation myocardial infarction and nonobstructive coronary artery disease: results from the Can Rapid Risk Stratification of Unstable Angina Patients Suppress Adverse Outcomes with Early Implementation of the ACC/AHA Guidelines (CRUSADE) quality improvement initiative.
    Gehrie ER; Reynolds HR; Chen AY; Neelon BH; Roe MT; Gibler WB; Ohman EM; Newby LK; Peterson ED; Hochman JS
    Am Heart J; 2009 Oct; 158(4):688-94. PubMed ID: 19781432
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Platelet-to-Lymphocyte Ratio Predicts Contrast-Induced Nephropathy in Patients With Non-ST-Segment Elevation Acute Coronary Syndrome.
    Kocas C; Yildiz A; Abaci O; Karaca OS; Firdin N; Dalgic Y; Bostan C; Ersanli M
    Angiology; 2015 Nov; 66(10):964-8. PubMed ID: 25852211
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Platelet reactivity evaluated with the VASP assay following ticagrelor loading dose in acute coronary syndrome patients undergoing percutaneous coronary intervention.
    Laine M; Toesca R; Berbis J; Frere C; Barnay P; Pansieri M; Peyre JP; Michelet P; Bessereau J; Camilleri E; Helaf O; Camaleonte M; Paganelli F; Dignat-George F; Bonello L
    Thromb Res; 2013 Jul; 132(1):e15-8. PubMed ID: 23726090
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Platelets and white blood cell subpopulations among patients with myocardial infarction and unstable angina.
    Avramakis G; Papadimitraki E; Papakonstandinou D; Liakou K; Zidianakis M; Dermitzakis A; Mikhailidis DP; Ganotakis ES
    Platelets; 2007 Feb; 18(1):16-23. PubMed ID: 17365849
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Current patterns of antithrombotic and revascularisation therapy in patients hospitalised for acute coronary syndromes. Data from the Polish subset of the EPICOR study.
    Wojtkowska I; Stępińska J; Stępień-Wojno M; Sobota M; Kopaczewski J; Reszka Z; Kurzelewski M; Medina J
    Kardiol Pol; 2017; 75(5):445-452. PubMed ID: 28281731
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Long-term outcomes for women versus men with unstable angina/non-ST-segment elevation myocardial infarction managed medically without revascularization: insights from the TaRgeted platelet Inhibition to cLarify the Optimal strateGy to medicallY manage Acute Coronary Syndromes trial.
    Clemmensen P; Roe MT; Hochman JS; Cyr DD; Neely ML; McGuire DK; Cornel JH; Huber K; Zamoryakhin D; White HD; Armstrong PW; Fox KA; Prabhakaran D; Ohman EM;
    Am Heart J; 2015 Oct; 170(4):695-705.e5. PubMed ID: 26386793
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Prognostic value of platelet indices after acute myocardial infarction treated with primary percutaneous coronary intervention.
    Rechciński T; Jasińska A; Foryś J; Krzemińska-Pakuła M; Wierzbowska-Drabik K; Plewka M; Peruga JZ; Kasprzak JD
    Cardiol J; 2013; 20(5):491-8. PubMed ID: 24469872
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical management and hospital outcomes of acute coronary syndrome patients in Mexico: The Third National Registry of Acute Coronary Syndromes (RENASICA III).
    Martinez-Sanchez C; Borrayo G; Carrillo J; Juarez U; Quintanilla J; Jerjes-Sanchez C;
    Arch Cardiol Mex; 2016; 86(3):221-32. PubMed ID: 27256475
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical and prognostic comparison between left ventricular transient dyskinesia and a first non-ST-segment elevation acute coronary syndrome.
    Núñez-Gil IJ; Fernández-Ortiz A; Pérez-Isla L; Luaces M; García-Rubira JC; Vivas D; Gonzalez JJ; Alonso J; Zamorano JL; Macaya C
    Coron Artery Dis; 2008 Nov; 19(7):449-53. PubMed ID: 18923239
    [TBL] [Abstract][Full Text] [Related]  

  • 58. White blood cell count to mean platelet volume ratio as a novel non-invasive marker predicting long-term outcomes in patients with non-ST elevation acute coronary syndrome.
    Dehghani MR; Rezaei Y; Taghipour-Sani L
    Cardiol J; 2015; 22(4):437-45. PubMed ID: 25733319
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical outcomes for prasugrel versus clopidogrel in patients with unstable angina or non-ST-elevation myocardial infarction: an analysis from the TRITON-TIMI 38 trial.
    De Servi S; Goedicke J; Schirmer A; Widimsky P
    Eur Heart J Acute Cardiovasc Care; 2014 Dec; 3(4):363-72. PubMed ID: 24818952
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Neutrophil count on admission predicts major in-hospital events in patients with a non-ST-segment elevation acute coronary syndrome.
    Karabinos I; Koulouris S; Kranidis A; Pastromas S; Exadaktylos N; Kalofoutis A
    Clin Cardiol; 2009 Oct; 32(10):561-8. PubMed ID: 19911351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.